Logo image of PHIA.AS

KONINKLIJKE PHILIPS NV (PHIA.AS) Stock Fundamental Analysis

Europe - AMS:PHIA - NL0000009538 - Common Stock

25.03 EUR
-0.38 (-1.5%)
Last: 11/13/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, PHIA scores 3 out of 10 in our fundamental rating. PHIA was compared to 60 industry peers in the Health Care Equipment & Supplies industry. PHIA may be in some trouble as it scores bad on both profitability and health. PHIA is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year PHIA was profitable.
In the past year PHIA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: PHIA reported negative net income in multiple years.
PHIA had a positive operating cash flow in 4 of the past 5 years.
PHIA.AS Yearly Net Income VS EBIT VS OCF VS FCFPHIA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

1.2 Ratios

The Return On Assets of PHIA (0.61%) is worse than 60.00% of its industry peers.
PHIA's Return On Equity of 1.56% is on the low side compared to the rest of the industry. PHIA is outperformed by 60.00% of its industry peers.
The Return On Invested Capital of PHIA (4.27%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 0.61%
ROE 1.56%
ROIC 4.27%
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
PHIA.AS Yearly ROA, ROE, ROICPHIA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

PHIA has a worse Profit Margin (0.91%) than 60.00% of its industry peers.
PHIA has a Operating Margin of 6.11%. This is comparable to the rest of the industry: PHIA outperforms 46.67% of its industry peers.
PHIA's Operating Margin has declined in the last couple of years.
PHIA's Gross Margin of 43.85% is on the low side compared to the rest of the industry. PHIA is outperformed by 68.33% of its industry peers.
In the last couple of years the Gross Margin of PHIA has remained more or less at the same level.
Industry RankSector Rank
OM 6.11%
PM (TTM) 0.91%
GM 43.85%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
PHIA.AS Yearly Profit, Operating, Gross MarginsPHIA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PHIA is destroying value.
Compared to 1 year ago, PHIA has less shares outstanding
PHIA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, PHIA has a worse debt to assets ratio.
PHIA.AS Yearly Shares OutstandingPHIA.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
PHIA.AS Yearly Total Debt VS Total AssetsPHIA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

An Altman-Z score of 1.98 indicates that PHIA is not a great score, but indicates only limited risk for bankruptcy at the moment.
PHIA's Altman-Z score of 1.98 is in line compared to the rest of the industry. PHIA outperforms 46.67% of its industry peers.
The Debt to FCF ratio of PHIA is 19.41, which is on the high side as it means it would take PHIA, 19.41 years of fcf income to pay off all of its debts.
PHIA has a Debt to FCF ratio (19.41) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.69 indicates that PHIA is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.69, PHIA is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 19.41
Altman-Z 1.98
ROIC/WACC0.67
WACC6.38%
PHIA.AS Yearly LT Debt VS Equity VS FCFPHIA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

PHIA has a Current Ratio of 1.26. This is a normal value and indicates that PHIA is financially healthy and should not expect problems in meeting its short term obligations.
PHIA has a worse Current ratio (1.26) than 63.33% of its industry peers.
PHIA has a Quick Ratio of 1.26. This is a bad value and indicates that PHIA is not financially healthy enough and could expect problems in meeting its short term obligations.
PHIA has a Quick ratio of 0.81. This is in the lower half of the industry: PHIA underperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.81
PHIA.AS Yearly Current Assets VS Current LiabilitesPHIA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.16% over the past year.
The Earnings Per Share has been decreasing by -7.17% on average over the past years.
PHIA shows a decrease in Revenue. In the last year, the revenue decreased by -0.81%.
Measured over the past years, PHIA shows a small growth in Revenue. The Revenue has been growing by 1.00% on average per year.
EPS 1Y (TTM)12.16%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%0.5%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-0.14%

3.2 Future

PHIA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.68% yearly.
The Revenue is expected to grow by 3.65% on average over the next years.
EPS Next Y0.24%
EPS Next 2Y5.1%
EPS Next 3Y7.59%
EPS Next 5Y12.68%
Revenue Next Year-1.93%
Revenue Next 2Y0.54%
Revenue Next 3Y1.79%
Revenue Next 5Y3.65%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PHIA.AS Yearly Revenue VS EstimatesPHIA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
PHIA.AS Yearly EPS VS EstimatesPHIA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1 1.5 2 2.5

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 17.38, PHIA is valued on the expensive side.
Based on the Price/Earnings ratio, PHIA is valued cheaply inside the industry as 85.00% of the companies are valued more expensively.
PHIA is valuated rather cheaply when we compare the Price/Earnings ratio to 25.91, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 16.36, PHIA is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PHIA indicates a somewhat cheap valuation: PHIA is cheaper than 71.67% of the companies listed in the same industry.
PHIA is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.57, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.38
Fwd PE 16.36
PHIA.AS Price Earnings VS Forward Price EarningsPHIA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PHIA is valued a bit cheaper than 73.33% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as PHIA.
Industry RankSector Rank
P/FCF 55.53
EV/EBITDA 13.02
PHIA.AS Per share dataPHIA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)73.16
PEG (5Y)N/A
EPS Next 2Y5.1%
EPS Next 3Y7.59%

0

5. Dividend

5.1 Amount

PHIA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

KONINKLIJKE PHILIPS NV

AMS:PHIA (11/13/2025, 7:00:00 PM)

25.03

-0.38 (-1.5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)02-17 2026-02-17/amc
Inst Owners47.54%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap24.10B
Revenue(TTM)18.02B
Net Income(TTM)162.00M
Analysts74.81
Price Target27.39 (9.43%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP0.62%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.64%
Min EPS beat(2)22.24%
Max EPS beat(2)31.04%
EPS beat(4)2
Avg EPS beat(4)6.19%
Min EPS beat(4)-16.56%
Max EPS beat(4)31.04%
EPS beat(8)3
Avg EPS beat(8)-1.09%
EPS beat(12)5
Avg EPS beat(12)15.29%
EPS beat(16)5
Avg EPS beat(16)3.51%
Revenue beat(2)0
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-1.97%
Max Revenue beat(2)-1.96%
Revenue beat(4)0
Avg Revenue beat(4)-3.05%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)2
Avg Revenue beat(12)-1.61%
Revenue beat(16)2
Avg Revenue beat(16)-1.84%
PT rev (1m)0.42%
PT rev (3m)5.61%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.41%
EPS NY rev (1m)-0.18%
EPS NY rev (3m)-8.83%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-0.85%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-1.18%
Valuation
Industry RankSector Rank
PE 17.38
Fwd PE 16.36
P/S 1.35
P/FCF 55.53
P/OCF 21.93
P/B 2.32
P/tB N/A
EV/EBITDA 13.02
EPS(TTM)1.44
EY5.75%
EPS(NY)1.53
Fwd EY6.11%
FCF(TTM)0.45
FCFY1.8%
OCF(TTM)1.14
OCFY4.56%
SpS18.54
BVpS10.78
TBVpS-1.76
PEG (NY)73.16
PEG (5Y)N/A
Graham Number18.69
Profitability
Industry RankSector Rank
ROA 0.61%
ROE 1.56%
ROCE 5.69%
ROIC 4.27%
ROICexc 4.72%
ROICexgc 15.5%
OM 6.11%
PM (TTM) 0.91%
GM 43.85%
FCFM 2.43%
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y10.6%
ROICexgc growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-Score8
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 19.41
Debt/EBITDA 3.01
Cap/Depr 51.35%
Cap/Sales 3.72%
Interest Coverage 4
Cash Conversion 46.06%
Profit Quality 267.9%
Current Ratio 1.26
Quick Ratio 0.81
Altman-Z 1.98
F-Score8
WACC6.38%
ROIC/WACC0.67
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.16%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%0.5%
EPS Next Y0.24%
EPS Next 2Y5.1%
EPS Next 3Y7.59%
EPS Next 5Y12.68%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-0.14%
Revenue Next Year-1.93%
Revenue Next 2Y0.54%
Revenue Next 3Y1.79%
Revenue Next 5Y3.65%
EBIT growth 1Y476.21%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year48.14%
EBIT Next 3Y21.01%
EBIT Next 5YN/A
FCF growth 1Y3516.67%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y43.47%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%

KONINKLIJKE PHILIPS NV / PHIA.AS FAQ

Can you provide the ChartMill fundamental rating for KONINKLIJKE PHILIPS NV?

ChartMill assigns a fundamental rating of 3 / 10 to PHIA.AS.


Can you provide the valuation status for KONINKLIJKE PHILIPS NV?

ChartMill assigns a valuation rating of 4 / 10 to KONINKLIJKE PHILIPS NV (PHIA.AS). This can be considered as Fairly Valued.


Can you provide the profitability details for KONINKLIJKE PHILIPS NV?

KONINKLIJKE PHILIPS NV (PHIA.AS) has a profitability rating of 2 / 10.


How financially healthy is KONINKLIJKE PHILIPS NV?

The financial health rating of KONINKLIJKE PHILIPS NV (PHIA.AS) is 2 / 10.


What is the expected EPS growth for KONINKLIJKE PHILIPS NV (PHIA.AS) stock?

The Earnings per Share (EPS) of KONINKLIJKE PHILIPS NV (PHIA.AS) is expected to grow by 0.24% in the next year.